Cargando…

P1693: PATIENT-REPORTED OUTCOMES IN LYMPHOMA TRIALS: A SYSTEMATIC REVIEW

Detalles Bibliográficos
Autores principales:	Laane, Edward, Salek, Sam, Oliva, Esther, Skoetz, Nicole, Csenar, Mario, Schroer, Julia, Oeser, Annika, Ionova, Tatyana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429848/ http://dx.doi.org/10.1097/01.HS9.0000973644.98699.04

Ejemplares similares

P1705: PATIENT-REPORTED OUTCOMES IN MYELOPROLIFERATIVE NEOPLASMS IN CLINICAL TRIALS: A SYSTEMATIC REVIEW
por: Oliva, E. N., et al.
Publicado: (2022)

The Reporting, Use, and Validity of Patient-Reported Outcomes in Multiple Myeloma in Clinical Trials: A Systematic Literature Review
por: Salek, Sam, et al.
Publicado: (2022)

P1693: THROMBOMODULIN RESISTANCE: A NEW PROTHROMBOTIC PATHWAY IN COVID-19
por: Montaño, A., et al.
Publicado: (2022)

P1688: LIVING WITH ACUTE LEUKEMIA: A GLOBAL SURVEY OF PATIENTS AND CARERS EXPERIENCE
por: Nier, Samantha, et al.
Publicado: (2023)

1693. Risk Factors and Outcomes of Histologic Acute Graft Pyelonephritis following Kidney Transplantation
por: Powers, Harry Ross, et al.
Publicado: (2020)

Safety of Adalimumab and Predictors of Adverse Events in 1693 Japanese Patients with Crohn’s Disease
por: Ogata, Haruhiko, et al.
Publicado: (2016)

“Medicine does not have to cure the poor”. The thought of Giovanni Bianchi (1693-1775)
por: Licata, Marta, et al.
Publicado: (2019)

Mother and child were saved: the memoirs (1693–1740) of the Frisian midwife Catharina Schrader
por: Eccles, Audrey
Publicado: (1988)

1693. Risk Factors Associated with Mortality of Invasive Aspergillosis in King Chulalongkorn Memorial Hospital
por: Jutivorakool, Kamonwan, et al.
Publicado: (2019)

P1724: QUALITY OF LIFE AND UNMET NEEDS AMONG PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASM PATIENTS: RESULTS OF THE NATIONWIDE SURVEY
por: Ionova, T., et al.
Publicado: (2022)

1693. Incidence of Pneumococcal Disease in Children ≤48 Months Old in the United States: 2010-2019
por: Mohanty, Salini, et al.
Publicado: (2023)

PB2673: EXPERIENCES AND VIEWS OF LEUKEMIA CARERS: A GLOBAL SURVEY
por: Nier, Samantha, et al.
Publicado: (2023)

The enigmatic 1693 AD tsunami in the eastern Mediterranean Sea: new insights on the triggering mechanisms and propagation dynamics
por: Scicchitano, Giovanni, et al.
Publicado: (2022)

P1692: UNMET NEEDS IN PATIENTS WITH “LOW RISK” POLYCYTHEMIA VERA (PV): SYMPTOM BURDEN AND QUALITY OF LIFE
por: Nikitina, Tatiana, et al.
Publicado: (2023)

Appraisal of patient-reported outcome measures in analogous diseases and recommendations for use in phase II and III clinical trials of pyruvate kinase deficiency
por: Salek, M. S., et al.
Publicado: (2018)

(-)-SCR1693 Protects against Memory Impairment and Hippocampal Damage in a Chronic Cerebral Hypoperfusion Rat Model
por: Zhu, Xiaoyin, et al.
Publicado: (2016)

P1072: SIGNIFICANT PREDICTORS OF DECREASED BONE MINERAL DENSITY IN PATIENTS WITH HODGKIN’S LYMPHOMA
por: Voytko, Mariya, et al.
Publicado: (2023)

Transmembrane Protein LMxysn_1693 of Serovar 4h Listeria monocytogenes Is Associated with Bile Salt Resistance and Intestinal Colonization
por: Jin, Fanxin, et al.
Publicado: (2022)

1693P Accurate triage may be efficacious in selecting patients who could safely continue anticancer therapy during SARS-CoV-2 pandemic
por: Gurizzan, C., et al.
Publicado: (2020)

Fructosuria and recurrent hypoglycemia in a patient with a novel c.1693T>A variant in the 3′ untranslated region of the aldolase B gene
por: Morales-Alvarez, Martha Catalina, et al.
Publicado: (2019)

Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study
por: Goswami, Pushpendra, et al.
Publicado: (2020)

Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity
por: Goswami, Pushpendra, et al.
Publicado: (2020)

Assessment of the 1693 tsunami wave generation and propagation simulation based on multiple focal mechanism scenarios for recent disaster mitigation in eastern sicily, Italy
por: Tri Laksono, FX Anjar
Publicado: (2023)

P1240: MICROBIOME DIVERSITY IN PATIENTS WITH LYMPHOMA
por: Dlouha, Lucie, et al.
Publicado: (2023)

P1205: PROGNOSTIC ROLE OF TUMOR P53 MUTATION IN DIFFUSE LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Ma, J., et al.
Publicado: (2022)

P1653: INFLAMMATION MEDIATED THROMBUS FORMATION IN LYMPHOMAS
por: Antic, Darko, et al.
Publicado: (2023)

PB2672: EXPLORING UNMET NEEDS OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS AND CAREGIVERS IN A NATIONAL ITALIAN SURVEY
por: Crisà, Elena, et al.
Publicado: (2023)

P1243: FUNCTIONAL PRECISION ONCOLOGY FOR FOLLICULAR LYMPHOMA WITH PATIENT-DERIVED XENOGRAFT IN AVIAN EMBRYOS.
por: Zala, Manon, et al.
Publicado: (2023)

P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA
por: Jacobsen, Austin, et al.
Publicado: (2023)

P1113: COMPARATIVE EFFICACY OF ZANUBRUTINIB (ZANU) VERSUS RITUXIMAB (RTX) IN RELAPSED MARGINAL ZONE LYMPHOMA (MZL): MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC)
por: Thieblemont, Catherine, et al.
Publicado: (2023)

P1113: PROGNOSTIC ROLE OF GENETIC ABNORMALITIES IN MANTLE CELL LYMPHOMA
por: Kleina, E., et al.
Publicado: (2022)

P1307: TESTING THE IMPORTANCE OF ANTIOXIDANTS ON THE PATHOGENESIS OF B CELL LYMPHOMA
por: Yao, H., et al.
Publicado: (2022)

P1707: FACTORS ASSOCIATED WITH A LYMPHOMA DIAGNOSIS PRIOR TO BIOPSY
por: Ejaz, A., et al.
Publicado: (2022)

P1260: UNRAVELING THE GENETICS OF TRANSFORMED SPLENIC MARGINAL ZONE LYMPHOMA
por: Grau, M., et al.
Publicado: (2022)

P1093: MATCHING-ADJUSTED INDIRECT COMPARISON (MAIC) OF ZANUBRUTINIB (ZANU) VERSUS IBRUTINIB (IBRU) IN RELAPSED/REFRACTORY MARGINAL ZONE LYMPHOMA (R/R MZL)
por: Thieblemont, Catherine, et al.
Publicado: (2023)

P1461: CAR-T VS. STANDARD OF CARE AS SECOND LINE TREATMENT FOR LARGE B CELL LYMPHOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Shargian, L., et al.
Publicado: (2022)

P1646: A SYSTEMATIC REVIEW AND META‐ANALYSIS OF RANDOMIZED CONTROLLED TRIALS ON PRIMARY AMBULATORY THROMBOPROPHYLAXIS (PATP) IN PATIENTS WITH LYMPHOMA RECEIVING CHEMOTHERAPY
por: Htut, Thura, et al.
Publicado: (2023)

P1217: TARGETING HSP110 IN COMBINATION WITH SELINEXOR IN PRIMARY MEDIASTINAL B-CELL LYMPHOMA AND IN CLASSICAL HODGKIN LYMPHOMA INHIBITS STAT6 ACTIVATION AND IMPAIRS LYMPHOMA CELL GROWTH
por: Durand, Manon, et al.
Publicado: (2023)

Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study
por: Goswami, Pushpendra, et al.
Publicado: (2020)

Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO
por: Goswami, Pushpendra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vqdnof9cqqunt38d0j1bukncoe